HSHHSH Health Technology Supplier Hub
Home › Suppliers › Infermedica › Risk

Infermedica: risk summary

Summaries are drawn from public sources and link to them. HSH does not give a risk rating: read the summary and sources and reach your own view. Unproven allegations are labelled as such. Suppliers can submit a response, which is shown alongside.

Financial

Latest full-year results from official filings.

Not stock-market listed and no listed parent identified, so no public annual accounts were found.

Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.

Researched 8 Nov 2026

Adverse media

Credible news about incidents, disputes, legal action or restructuring in the last 24 months.

No adverse media involving Infermedica found in HSH's search of the last 24 months.

Researched 10 Nov 2026

Cyber & information governance

Data breaches, cyber incidents, regulator action and assurance status.

No data breaches or cyber incidents involving Infermedica found in HSH's search of the last 24 months. NHS DSPT status not yet checked.

Researched 10 Nov 2026

Regulatory & clinical safety

Recalls, safety notices, regulator action and clinical safety concerns.

Infermedica says its Clinical AI Triage is an EU MDR Class IIb medical device registered with the MHRA. No recalls, safety notices or regulatory actions involving Infermedica found in HSH's search of the last 24 months.

Researched 10 Nov 2026